Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Journal of Cutaneous Medicine and Surgery
|
October 31, 2001
One-year followup on the impact of a sun awareness curriculum on medical students' knowledge, attitudes, and behavior
K E Liu, B Barankin, J Howard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 11, 2018
Psoriasis patients' preference for an aerosol foam topical formulation
R Vender, M J Gooderham, L C Guenther, et al.
Journal of the American Academy of Dermatology
|
March 1, 1985
An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris
J L Lesher, D K Chalker, J G Smith, et al.
The British Journal of Dermatology
|
September 4, 2020
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial
A Blauvelt, C Leonardi, B Elewski, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Journal of Cutaneous Medicine and Surgery
|
October 31, 2001
One-year followup on the impact of a sun awareness curriculum on medical students' knowledge, attitudes, and behavior
K E Liu, B Barankin, J Howard, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
April 11, 2018
Psoriasis patients' preference for an aerosol foam topical formulation
R Vender, M J Gooderham, L C Guenther, et al.
Journal of the American Academy of Dermatology
|
March 1, 1985
An evaluation of a 2% erythromycin ointment in the topical therapy of acne vulgaris
J L Lesher, D K Chalker, J G Smith, et al.
The British Journal of Dermatology
|
September 4, 2020
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial
A Blauvelt, C Leonardi, B Elewski, et al.
Page
of 2